Kathy Astrahantseff

2.2k total citations
36 papers, 1.2k citations indexed

About

Kathy Astrahantseff is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Kathy Astrahantseff has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Kathy Astrahantseff's work include Neuroblastoma Research and Treatments (24 papers), Cancer, Hypoxia, and Metabolism (6 papers) and CAR-T cell therapy research (5 papers). Kathy Astrahantseff is often cited by papers focused on Neuroblastoma Research and Treatments (24 papers), Cancer, Hypoxia, and Metabolism (6 papers) and CAR-T cell therapy research (5 papers). Kathy Astrahantseff collaborates with scholars based in Germany, France and United States. Kathy Astrahantseff's co-authors include Angelika Eggert, Johannes H. Schulte, Alexander Schramm, Lukas C. Heukamp, Ying Cao, Tilman Borggrefe, Soizic Bourteele, Michael Winkler, Hedwig E. Deubzer and Walter Knöchel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular and Cellular Biology.

In The Last Decade

Kathy Astrahantseff

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Astrahantseff Germany 17 645 449 383 308 120 36 1.2k
Delphine Lequin France 6 618 1.0× 717 1.6× 370 1.0× 299 1.0× 65 0.5× 10 1.0k
Jana Karásková Canada 17 870 1.3× 115 0.3× 333 0.9× 379 1.2× 248 2.1× 22 1.4k
Margareta Wilhelm Sweden 19 1.1k 1.6× 149 0.3× 340 0.9× 703 2.3× 47 0.4× 30 1.4k
Hilary Blair United States 12 429 0.7× 152 0.3× 319 0.8× 169 0.5× 703 5.9× 17 1.2k
Karisa C. Schreck United States 16 946 1.5× 140 0.3× 290 0.8× 418 1.4× 505 4.2× 55 1.4k
M. Eva Alonso Spain 22 683 1.1× 257 0.6× 192 0.5× 153 0.5× 266 2.2× 27 1.1k
Lindsay Kilburn United States 17 462 0.7× 399 0.9× 177 0.5× 189 0.6× 637 5.3× 68 1.1k
Cynthia Winter United States 12 808 1.3× 928 2.1× 536 1.4× 328 1.1× 66 0.6× 15 1.3k
Carl Koschmann United States 18 428 0.7× 188 0.4× 249 0.7× 181 0.6× 530 4.4× 79 935
Jochen Buechner Norway 14 990 1.5× 204 0.5× 259 0.7× 316 1.0× 140 1.2× 33 1.4k

Countries citing papers authored by Kathy Astrahantseff

Since Specialization
Citations

This map shows the geographic impact of Kathy Astrahantseff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Astrahantseff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Astrahantseff more than expected).

Fields of papers citing papers by Kathy Astrahantseff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Astrahantseff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Astrahantseff. The network helps show where Kathy Astrahantseff may publish in the future.

Co-authorship network of co-authors of Kathy Astrahantseff

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Astrahantseff. A scholar is included among the top collaborators of Kathy Astrahantseff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Astrahantseff. Kathy Astrahantseff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michallek, Florian, Marc Dewey, Barbara Hero, et al.. (2025). Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival. Radiology Imaging Cancer. 8(1). e250070–e250070.
2.
Lázaro, Juan José, Lorenz Bastian, Claudia D. Baldus, et al.. (2025). Inhibiting H3K27 Demethylases Downregulates CREB ‐ CREBBP , Overcoming Resistance in Relapsed Acute Lymphoblastic Leukemia. Cancer Medicine. 14(1). 1–7. 1 indexed citations
3.
Szymansky, Annabell, Kathy Astrahantseff, Carolina Rosswog, et al.. (2025). Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma. Cancer Research Communications. 5(1). 167–177.
4.
Afanasyeva, Elena, M. Schneider, Christopher Schröder, et al.. (2024). A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications Biology. 7(1). 919–919. 2 indexed citations
5.
Thorwarth, Anne, Kathy Astrahantseff, Annabell Szymansky, et al.. (2024). Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. Journal of Clinical Medicine. 13(19). 5995–5995. 1 indexed citations
6.
Sprüssel, Annika, Takayoshi Suzuki, Naoki Miyata, et al.. (2024). Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine. 13(20). 6081–6081.
7.
Klaus, Anika, Annika Winkler, Kathy Astrahantseff, et al.. (2021). Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers. 13(21). 5489–5489. 9 indexed citations
8.
Lam, Tobias, Anika Klaus, Annika Winkler, et al.. (2021). A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization. Frontiers in Immunology. 12. 689697–689697. 39 indexed citations
9.
Olk, Nadine, Kathy Astrahantseff, Lasse D. Jensen, et al.. (2020). Fast, In Vivo Model for Drug-Response Prediction in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers. 12(7). 1883–1883. 15 indexed citations
10.
Sprüssel, Annika, Kathy Astrahantseff, Karin Schmelz, et al.. (2020). Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction. Journal of Molecular Diagnostics. 22(11). 1309–1323. 11 indexed citations
11.
Zasada, Christin, Katharina Baum, Guido Mastrobuoni, et al.. (2020). Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy againstMYCN‐amplified neuroblastoma. International Journal of Cancer. 148(5). 1219–1232. 15 indexed citations
12.
Lodrini, Marco, Annika Sprüssel, Kathy Astrahantseff, et al.. (2017). Using droplet digital PCR to analyzeMYCNandALKcopy number in plasma from patients with neuroblastoma. Oncotarget. 8(49). 85234–85251. 50 indexed citations
13.
Simon, Thorsten, Barbara Hero, Johannes H. Schulte, et al.. (2017). 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors. Klinische Pädiatrie. 229(3). 147–167. 66 indexed citations
14.
Pajtler, Kristian W., Sandra Ackermann, Kristina Althoff, et al.. (2016). The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models. Oncotarget. 8(4). 6730–6741. 31 indexed citations
15.
Eckert, Cornelia, Nikola Hagedorn, Georg Mann, et al.. (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia. 29(8). 1648–1655. 43 indexed citations
16.
Althoff, Kristina, Anneleen Beckers, Emma Bell, et al.. (2014). A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies. Oncogene. 34(26). 3357–3368. 87 indexed citations
17.
Esser, R., Wolfgang Glienke, Konrad Bochennek, et al.. (2011). Detection of Neuroblastoma Cells During Clinical Follow Up: Advanced Flow Cytometry and RT-PCR for Tyrosine Hydroxylase Using Both Conventional and Real-Time PCR. Klinische Pädiatrie. 223(6). 326–331. 3 indexed citations
18.
Schramm, Alexander, Johannes H. Schulte, Kathy Astrahantseff, et al.. (2005). Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Letters. 228(1-2). 143–153. 98 indexed citations
19.
Waha, Andreas, Helmut K. Wolf, Rolf Fimmers, et al.. (1996). Lack of prognostic relevance of alterations in the epidermal growth factor receptor—transforming growth factor-α pathway in human astrocytic gliomas. Journal of neurosurgery. 85(4). 634–641. 74 indexed citations
20.
Astrahantseff, Kathy & John E. Morris. (1994). Estradiol-17β stimulates proliferation of uterine epithelial cells cultured with stromal cells but not cultured separately. In Vitro Cellular & Developmental Biology - Animal. 30(11). 769–776. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Delphine Lequin Breakdown of academic impact, for papers by Jana Karásková Breakdown of academic impact, for papers by Margareta Wilhelm Breakdown of academic impact, for papers by Hilary Blair Breakdown of academic impact, for papers by Karisa C. Schreck Breakdown of academic impact, for papers by M. Eva Alonso Breakdown of academic impact, for papers by Lindsay Kilburn Breakdown of academic impact, for papers by Cynthia Winter Breakdown of academic impact, for papers by Carl Koschmann Breakdown of academic impact, for papers by Jochen Buechner
Rankless by CCL
2026